1. Overview of Congenital Hepatic Fibrosis in Pediatrics: A Review
- Author
-
Fahad Amrh AlAjmi, Khalid Mohammed A. Aladhadh, Ebtesam Ali S. Almadi, Naif Mohammed Al-Wagdani, Mansour Hemaid Alhelali, Nasser Naif Alsuhaymi, Ahmed Saeed S. Banheem, Sarah jamal Almujil, and Ahmed Abdelsamie Fadl
- Abstract
Congenital hepatic fibrosis is a rare developmental illness caused by a ductal plate malformation, often known as ciliopathy or fibrocystic liver disease. Hepatosplenomegaly and portal hypertension are two symptoms. The disease affects 1/10000–20000 people. frequently associated with a variety of illnesses caused by genetic abnormalities, such as autosomal recessive polycystic kidney disease (ARPKD) and Caroli syndrome. There hasn't been a way to stop or reverse the progression of congenital hepatic fibrosis until now. Clinical trials of anti-fibrotic medicines such as colchicine, interferon gamma, angiotensin II receptor blockers, pirfenidone, and ursodeoxycholic acid found no significant benefit. The only known cure for CHF is liver transplantation, which is recommended when the condition has progressed to the point when symptoms of liver failure have appeared. In this article we will be making overview of the disease. It’s symptoms and diagnosis, different treatment method, and we will compare some of the articles published about the disease.
- Published
- 2021
- Full Text
- View/download PDF